Home > Boards > US Listed > Medical - Drugs > Inflarx N.V. (IFRX)

Maybe something is now brewing for covid??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
now invest Member Profile
 
Followed By 44
Posts 11,582
Boards Moderated 0
Alias Born 02/14/07
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 6/8/2021 7:31:10 AM
InflaRx Doses First Patient in Multicenter Phase II Clinical Trial in Cutaneous Squamous Cell Carcinoma with Vilobelimab GlobeNewswire Inc. - 6/8/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/21/2021 8:16:59 AM
Tony Gibney Joins InflaRx Board of Directors GlobeNewswire Inc. - 5/21/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/12/2021 4:31:22 PM
InflaRx reports Q1 results Seeking Alpha - 5/12/2021 7:41:13 AM
InflaRx Reports First Quarter 2021 Financial & Operating Results GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
InflaRx meets primary objective in mid-stage trial for vilobelimab in ANCA vasculitis Seeking Alpha - 5/12/2021 6:49:47 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/11/2021 4:31:01 PM
InflaRx Announces Positive Topline Results for Vilobelimab from the U.S. Phase II ANCA-Associated Vasculitis IXPLORE Study GlobeNewswire Inc. - 5/11/2021 4:30:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/3/2021 4:15:54 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/15/2021 7:53:50 AM
InflaRx completes enrollment in mid-stage vilobelimab skin disease trial Seeking Alpha - 4/15/2021 7:46:20 AM
InflaRx Completes Enrollment of Vilobelimab Phase IIa Study in Pyoderma Gangraenosum GlobeNewswire Inc. - 4/15/2021 7:30:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 3/25/2021 7:38:18 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/25/2021 7:28:40 AM
InflaRx reports FY results Seeking Alpha - 3/25/2021 6:51:35 AM
InflaRx Reports Full Year 2020 Financial & Operating Results GlobeNewswire Inc. - 3/25/2021 6:30:00 AM
PRTS, AMTX, ACAD and WTRH among after-hours movers Seeking Alpha - 3/8/2021 5:43:02 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/8/2021 4:17:27 PM
InflaRx to Present at Upcoming Investor Conferences GlobeNewswire Inc. - 3/3/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/1/2021 5:37:25 PM
InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants GlobeNewswire Inc. - 3/1/2021 4:01:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 2/26/2021 5:26:17 PM
InflaRx prices $75M capital raise Seeking Alpha - 2/25/2021 8:47:17 AM
now invest   Tuesday, 12/08/20 02:39:30 PM
Re: l2 hunter post# 481
Post # of 492 
Maybe something is now brewing for covid??

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences